Alva Review-Courier -

By Linda A. Johnson
AP Medical Writer 

Novel leukemia treatment could be 1st US gene therapy

 


A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S.

A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of Pennsylvania and Novartis Corp. The FDA usually follows recommendations from its expert panels, but isn't obligated to do so.

The therapy could be the first of a wave of treatments custom-made to target a patient's cancer. Called CAR-T, this type of therapy involves removing immune cells from a patients' blood, reprogramming them to create an army of ce...



For access to this article please sign in or subscribe.



 

Reader Comments(0)

 
 

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2020